Dendreon Corp (DNDN)

New phase 3's in the works.

DRUGS UNDER DEVELOPMENT

Whole new way of treating cancers, with treatment for breast cancer to follow treatment for prostate cancer. No more chemo or radiation. Amazing technology. Acts like a vaccine. Big companies putting big money into it, i.e. Fidelity Mutual Corp.

Investigational drug ready for FDA approval.

A new paradigm in fighting cancer

I think this may actually happen in closer to 1 year but will occur by the 24 month point for sure. As a health care professional I can honestly say that the data behind Provenge looks great, and when combined with the lack of side effects mean this agent will likely become a preferred option in its arena. I do not know an single oncologist who won't be trying to use this in earlier stages if they see the same results shown in IMPACT

SLAMDUNK !

Doing creative research in the fight against Cancer

FDA approval followed by large orders.

Up and coming in the fight to prevent cancer.

going to be approved it is a game changer in treating cancer,

Merriman has $50 price target and many analysts think DNDN will be bought out before 2010, and they will have a catalyst from submitting their app to the FDA in a few months...so the stock should outperform market in next 6 months...even though this does not count the huge April run-up. Anybody believe in NewWorldInvestor's $360 price target (not counting dilution vis share issuances)? Pretty interesting...
One must be skittish about long-term hold with DNDN, though, because they want insurance companies to pay about $60,000 per patient after it gets past the FDA and available in the USA market - to only give each patient a few extra months of life before dying. Because there are MANY drugs and treatments that aim to delay death from various cancers by only a few months, and they (almost) all cost tens of thousands per patient, you have to consider Obama and the insurance companies teaming up and targeting this area as a primary cause of PREDICTED/FUTURE healthcare cost growth. They will try to find a way to cut out insurance coverage for these kinds of very expensive treatments. Big ethical debate on the horizon, don't you think?
I hope patients and the economy's stability benefit from the emergence of simpler and cheaper PREVENTIVE treatments like the prostate cancer prevention drug from GTXI, that many folks (the ones who want the drug) can likely pay for themselves on a monthly basis, with only partial insurance co-pay.

Only drug of it's kind and there is almost 100% certainty that it will pass FDA.

Takeover target.

Might be a bit of a speculative play, but if its drug get to market, it will be a big winner.

Future looks really good from here....FDA approval, Row partner , and always a chance a big Pharma steps in and buys them out and thats not even considering thier pipeline potential for new products (breast cancer ) already in the works. If you missed the initial runup it's not to late , theres lots of upward potential as one or all of the possibilities i mentioned materialize. I sold 1/3 of my position after the Bear Raid Fiasco to cover my costs once trading resumed ($26.25/share) I'll sell another 1/3 at $60 and keep the last 1/3 for the long haul. Rumors of a possible split this summer to, like i said lots of things yet to happen that will move this stock higher. GLTA !

Once it starts selling its new drugs the revenues will be huge. Company should be trading at least at 50 by year end

Potential of Provenge is huge; pipeline is extremely promising; secured Cash to operate for the next few years; very little debt.

Drugs will get approved and used world wide